Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oliceridine for Analgesia After Cardiac Surgery

NCT06619145 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.

NCT NCT06619145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06619145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oliceridine for Analgesia After Cardiac Surgery
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 1, 2024
Completion date
October 30, 2026
Enrollment
270 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

oliceridine, postoperative cardiac surgery